🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 2 multicenter clinical trial assess the safety and efficacy of i...
Status
Unknown
Location
Scottsdale Research Institute
Start Date
2020-07-30
Trial ID
NCT04042545
The overarching goal of this study is to characterize the effects of ethano...
Status
Active Not Recruiting
Location
Biological Studies Unit, VA Connecticut Healthcare System
Start Date
2016-03
Trial ID
NCT02709954
Treatments Being Tested
This study will examine how a moderate dose of THC affects mood, stress res...
Status
Not Yet Recruiting
Location
Washington State University
Start Date
2026-07
Trial ID
NCT07296874
Our primary objective is to assess whether inhaling vaporized cannabis amel...
Status
Completed
Location
San Francisco General Hospital
Start Date
2014-08
Trial ID
NCT01771731
Treatments Being Tested
No actual human data for pharmacokinetics, metabolism, safety, pharmacodyna...
Status
Completed
Location
Algorithme Pharma.
Start Date
2017-03-01
Trial ID
NCT04314804
Delta-8-THC is an isomer of delta-9-THC that has become widely available du...
Status
Completed
Location
Johns Hopkins Behavioral Pharmacology Research Unit
Start Date
2024-07-01
Trial ID
NCT06218550
Treatments Being Tested
The purpose of this study is to try to understand and explain why HIV-infec...
Status
Completed
Location
Montefiore Medical Center
Start Date
2020-10-23
Trial ID
NCT03633721
The purpose of this study is to expand understanding of the effects of cann...
Status
Completed
Location
National Advanced Driving Simulator
Start Date
2012-07
Trial ID
NCT01620177
Treatments Being Tested
The acute effects of cannabis may differ between adolescents and adults. Fu...
Status
Completed
Location
University College London
Start Date
2019-03-11
Trial ID
NCT04851392
Background: Tetrahydrocannabinol (THC) is a partial CB1/CB2 agonist and ca...
Status
Terminated
Location
IMIM (Hospital del Mar Medical Research Institute)
Start Date
2020-03-03
Trial ID
NCT04316598
Treatments Being Tested